Review Article
Membrane Incorporation, Channel Formation, and Disruption of Calcium Homeostasis by Alzheimer's β-Amyloid Protein
Table 1
Characteristics of amyloidogenic proteins and the related peptides.
| Disease | Amyloidogenic protein or its fragment peptide and the primary sequence | β-sheet formation | Cytotoxicity | Channel formation | [Ca2+]i rise |
| Alzheimer’s disease | Aβ P(1–40) | | | | | DAEFRHDSGYEVHHQKLVFFAE | + | + | + | + | DVGSNKGAIIGLMVGGVV | Aβ P(40-1) | | | | | VVGGVMLGIIAGKNSGVDEAFFV | – | – | – | – | LKQHHVEYGSDHRFEAD | Aβ P(25-35) | | | | | DVGSNKGAII | + | + | + | + | Aβ P(1–42) | | | | | DAEFRHDSGYEVHHQKLVFFAEDV | + | + | + | + | GSNKGAIIGLMVGGVVIA |
| Prion disease | PrP106–126 (prion protein fragment) | | | | | KTNMKHMAGAAAAGAVVGGLG | + | + | + | + | Scramble PrP106–126 | | | | | NGAKALMGGHGATKVMVGAAA | – | – | – | – |
| Parkinson’s disease (DLB; diseases with Lewy bodies) | -synuclein NAC (a fragment of -synuclein) | | | | | EQVTNVGGAVVTGVTAVAQKTVEGAGSIAAA TGFV | + | + | + | + |
| Triplet-repeat disease | Polyglutamine | | | | | QQQQQQQQ— | + | + | + | n.d. |
| Diabetes mellitus | Human amylin | | | | | KCNTATCATQRLANFLVHSSNNFGAILSSTNVGSNTY | + | + | + | + | Rat amylin | | | | | KCNTATCATQRLANFLVRSSNNLGPVLPPTNVGSNTY | – | – | – | – |
| Medullary carcinoma of the thyroid | Calcitonin | | | | | CGNLSTCMLGTYTQDFNKFHTFPQTAIGVGAP | + | + | + | + |
|
|
n.d.: not determined.
|